- Editorial: The Impact of Microbiota and Cytokines on Inflammatory Bowel Disease. Kanauchi, Osamu; Mitsuyama, Keiichi // Current Pharmaceutical Design;6/21/2009, Vol. 15 Issue 18, p2049
The article discusses a special issue on the role of microbiota and cytokines in inflammatory bowel disease (IBD) including the therapeutic impact of manipulating microbiota in IBD, the effects of curcumin on IBD patients, and the role of interleukin-6 in IBD.
- Is interleukin-6 important in inflammatory bowel disease? Koss, K; Satsangi, J; Welsh, K I; Jewell, D P // Genes & Immunity;Feb2000, Vol. 1 Issue 3, p207
The IL-6 gene maps to an area of chromosome 7 known to be significant for susceptibility to inflammatory bowel disease. The functional effects of interleukin-6 (IL-6) polymorphisms in the 4th intron and in the 3' flanking region of IL-6 gene were studied in 192 inflammatory bowel disease...
- Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients Brown, Kurt A.; Back, Susan J.; Ruchelli, Eduardo D.; Markowitz, Jonathan; Mascarenhas, Maria; Verma, Ritu; Piccoli, David A.; Baldassano, Robert N. // American Journal of Gastroenterology;Oct2002, Vol. 97 Issue 10, p2603
OBJECTIVES:Understanding cytokine production patterns in early mucosal lesions of pediatric patients newly diagnosed with inflammatory bowel disease (IBD) may be critical to understanding IBD pathogenesis. Interleukin-6 (IL-6) has a central role in a multitude of immune system reactions;...
- enteritis. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p778
A definition of the medical term "enteritis," which refers to inflammation of the intestines, is presented.
- The Systematic review of Necrotizing Enterocolitis; Risk, Prevention and Outcomes. Gillani, S. Wasif; Oktavia, S. Yelly // HealthMed;Jun2010, Vol. 4 Issue 2, p297
Necrotizing Enterocolitis (NEC) is identified as a multifactoral disease among the neonates. Beside the large era of research still this disease is recognized as a thread to newborns. Early clinical trials emphasize on enteral fed but findings reflect the high incidence on feeding with unfed....
- Manchester University heads Â£10m EU-funded research network into inflammatory bowel disease. // Gastrointestinal Nursing;Apr2013, Vol. 11 Issue 3, p6
The article reports that the University of Manchester is leading a 10 million Sterling Pound, 5-year research network to identify better treatments for inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC).
- Methanogenesis in Irritable Bowel Syndrome: A Lot of Hot Air? Bajaj, Jasmohan; Gillevet, Patrick; Hylemon, Phillip // Digestive Diseases & Sciences;Dec2012, Vol. 57 Issue 12, p3045
No abstract available.
- Human Atrial Natriuretic Peptide Ameliorates LPS-Induced Acute Lung Injury in Rats. Koga, Hironori; Hagiwara, Satoshi; Shingu, Chihiro; Matsumoto, Shigekiyo; Yokoi, Isao; Noguchi, Takayuki // Lung;Jun2010, Vol. 188 Issue 3, p241
Acute lung injury, a common component of systemic inflammatory disease, is a life-threatening condition without many effective treatments. However, recent studies have demonstrated that the multifunctional human atrial natriuretic peptide (hANP) exerts anti-inflammatory effects. Therefore, we...
- Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease. Rose-John, Stefan; Mitsuyama, Keiichi; Matsumoto, Satoshi; Thaiss, Wolfgang M.; Scheller, J�rgen // Current Pharmaceutical Design;6/21/2009, Vol. 15 Issue 18, p2095
The complex pathogenesis of inflammatory bowel disease (IBD) and inflammation induced colon cancer involves a wide range of mediators including cytokines. Recent investigations underline the fundamental role of interleukin-6 (IL-6) signaling in the development and maintenance of IBD and for the...